Recap: ResMed Q2 Earnings

Comments
Loading...

ResMed RMD reported its Q2 earnings results on Wednesday, January 24, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

ResMed beat estimated earnings by 5.03%, reporting an EPS of $1.88 versus an estimate of $1.79.

Revenue was up $129.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 2.94% drop in the share price the next day.

Here's a look at ResMed's past performance:

Quarter Q1 2024 Q4 2023 Q3 2023 Q2 2023
EPS Estimate 1.62 1.67 1.59 1.60
EPS Actual 1.64 1.60 1.68 1.66
Revenue Estimate 1.10B 1.12B 1.05B 994.02M
Revenue Actual 1.10B 1.12B 1.12B 1.03B

To track all earnings releases for ResMed visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

RMD Logo
RMDResMed Inc
$220.40-2.39%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum61.31
Growth46.05
Quality66.77
Value21.24
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: